Dabur India has initiated legal action against Patanjali Ayurved in the Delhi High Court, accusing it of trademark infringement regarding the packaging of 'Dant Kanti Red' toothpaste. The court has allowed the suit to proceed following unsuccessful mediation efforts.
The lawsuit revolves around Patanjali's redesigned packaging for 'Dant Kanti Red', launched in December 2024. Dabur alleges that the new packaging closely resembles its own product, creating consumer confusion. The concern is not over the use of the word 'Red' or the symbolic pan leaf, but the overall package appearance, which it claims mirrors Dabur’s trade dress.
Justice Manmeet Pritam Singh Arora of the Delhi High Court confirmed that mediation between the two companies failed. As per Section 12A of the Commercial Courts Act, Dabur had fulfilled its pre-institution mediation obligations. The court proceeded with formal case registration, setting procedural timelines for further hearings.
The court granted Patanjali 30 days to submit its written statement supported by affidavit documents. Dabur would then have another 30 days to file a replication. The court warned that unsupported denials could attract cost implications. Document inspections will follow the Delhi High Court (Original Side) Rules, 2018.
Read More: Reliance Group to Invest ₹1,622 Crore in Campa Cola Bottling Plant in Karnataka!
India’s oral care market was valued at $2.03 billion in 2024 and is expected to rise to $3.2 billion by 2033, at a CAGR of 5.18%. With rising demand for herbal formulations using ingredients like neem and clove, brands like Dabur, Patanjali, and Himalaya have intensified competition. The segment’s traditional versus herbal narrative has fuelled multiple legal and branding rivalries.
Dabur's legal action against Patanjali over 'Dant Kanti Red' packaging adds to the fierce rivalry in India's oral care space. With mediation proving unsuccessful, the court will now determine the outcome based on trademark claims and design similarities.
Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in securities are subject to market risks. Read all related documents carefully before investing.
Published on: Aug 8, 2025, 1:29 PM IST
We're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
